Marijuana
Hundreds of patients turn to private cannabis clinics in UK
August 16, 2019Medical Communications Marijuana, NHS, UK, cannabis, medicinal cannabis, pharma
Hundreds of people have turned to private clinics, in an effort to gain access to medicinal cannabis in the UK, …
UK Government call for more research into medicinal cannabis
July 4, 2019Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CBMP, Marijuana, UK, medicinal cannabis, pharma, politics
The British government has called for more research into cannabis-based medicinal products (CBMPs). In a paper published on 3 July, …
Fewer opioids prescribed in states with medical marijuana, research shows
June 12, 2019Research and Development Marijuana, medicinal cannabis, opioids, pharma
Fewer opioids are prescribed in states with legal medical marijuana, according to research from University of Texas Medical Branch at …
Novartis inks deal with Canadian cannabis firm Tilray
December 18, 2018Research and Development Marijuana, Novartis, Sandoz, Tilray, cannabis
Shares in Canadian cannabis company Tilray jumped by more than 11% today after the British Columbia-based firm announced its entry …
CBD dampens activity in brain regions associated with psychosis, study shows
August 30, 2018Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study
Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …
Top Ten most popular articles on Pharmafile.com this week
March 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma
As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
GW Pharma releases positive data on cannabidiol-based Phase III trial
September 28, 2016Research and Development Epidiolex, GW Pharmaceuticals, Marijuana, Medical marijuana, cannabis
GW Pharmaceuticals’ Epidiolex is designed to treat seizures in a rare form of epilepsy called Lennox-Gaustaut Syndrome. GW pharmaceuticals published …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
